CVS Boasts That A New Pricing Model Will Lower Drug Costs For Health Plans. Will It?
By Ed Silverman. December 5, 2018.
Read More
FDA Promised a ‘Lower-Cost Option’ to Epi-Pen, But the Price Isn’t Any Lower
By Ed Silverman. November 27, 2018.
Read More
What Rebates? Express Scripts Touts A New Plan To Appease Critics Of The Opaque Drug-Pricing System
By Ed Silverman. November 13, 2018.
Read More
Never Mind the Rebates. Maybe Behind-the-Scenes Fees Are Boosting Drug Prices
By Ed Silverman. August 16, 2018.
Read More
In Prescription Drug Business, Will Amazon Partner with PBMs, Or Seek to Conquer Them?
By Casey Ross. July 16, 2018.
Read More
Ohio Peels Back The Curtain On A Lucrative PBM Profit Center
By Ed Silverman. June 22, 2018.
Read More
UnitedHealthcare will pass some rebates to consumers, but will this really lower drug prices?
By Ed Silverman. March 6, 2018.
Read More
Washington is taking aim at drug industry middlemen. But can it break their grip on a captive market?
By Casey Ross. February 16, 2018.
Read More
Hey, Amazon: As a pharmacy benefit manager, you could create real competition for drug prices
Op-Ed by Linda Cahn. November 15, 2017.
Read More
Q&A (with Linda Cahn): Pharma and PBMs are in a ‘Two Step Dance’ that Raises Drug Prices
by Ed Silverman. June 13, 2017.
Read More
Express Scripts and Some Drug Makers Say They Can Work Together To Lower Costs
by Ed Silverman. May 8, 2017.
Read More
A New Senate Bill Would Require PBMs to Disclose Some Rebate Info
by Ed Silverman. March 15, 2017.
Read More
The ‘Gouge Factor’: Big Companies Want Transparency In Drug Price Negotiations
by Ed Silverman. August 2, 2016.
Read More
Drug Spending Increase Slowed to 5.2 Percent Last Year, Express Scripts Says
by Ed Silverman. March 14, 2016.
Read More